title: Low-dose vemurafenib induces complete remission in a case of hairy-cell leukemia with a V600E mutation.
authors.affiliation: Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France. frederic.peyrade@nice.unicancer.fr
authors.forename: Frederic
authors.initials: F
authors.lastname: Peyrade
authors.forename: Daniel
authors.initials: D
authors.lastname: Re
authors.forename: Clemence
authors.initials: C
authors.lastname: Ginet
authors.forename: Lauris
authors.initials: L
authors.lastname: Gastaud
authors.forename: Maryline
authors.initials: M
authors.lastname: Allegra
authors.forename: Robert
authors.initials: R
authors.lastname: Ballotti
authors.forename: Antoine
authors.initials: A
authors.lastname: Thyss
authors.forename: Thorsten
authors.initials: T
authors.lastname: Zenz
authors.forename: Patrick
authors.initials: P
authors.lastname: Auberger
authors.forename: Guillaume
authors.initials: G
authors.lastname: Robert
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007211:Indoles / Q000008:administration & dosage / Q000627:therapeutic use*; D007943:Leukemia, Hairy Cell / Q000188:drug therapy* / Q000235:genetics*; D009154:Mutation; D047428:Protein Kinase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D048493:Proto-Oncogene Proteins B-raf / Q000235:genetics*; D012074:Remission Induction; D013449:Sulfonamides / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome; D000077484:Vemurafenib
chemical_list: D000970:Antineoplastic Agents; D007211:Indoles; D047428:Protein Kinase Inhibitors; D013449:Sulfonamides; D000077484:Vemurafenib; D048493:Proto-Oncogene Proteins B-raf